<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04620642</url>
  </required_header>
  <id_info>
    <org_study_id>69HCL20_0924</org_study_id>
    <nct_id>NCT04620642</nct_id>
  </id_info>
  <brief_title>Lyon Registry of Stroke Treated by Thrombolysis or Thrombectomy</brief_title>
  <acronym>RELATE</acronym>
  <official_title>Lyon Registry of Stroke Treated by Thrombolysis or Thrombectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospices Civils de Lyon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospices Civils de Lyon</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This observational study as an objective of characterizing the population of patients treated&#xD;
      within the neurovascular unit of the Pierre Wertheimer hospital (Hospices Civils de Lyon) in&#xD;
      order to determine their phenotype (age, sex, risk factors, etc.) and its evolution over&#xD;
      time. It also aims to assess the management of ischemic stroke (IS) in the neurovascular unit&#xD;
      of Pierre Wertheimer Hospital. We will assess in particular the pre-hospital and hospital&#xD;
      care times, the type of medical care (thrombolysis and / or thrombectomy) as well as the&#xD;
      efficiency of this care (effective recanalization, outcome of patient, etc.).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      All patient who has had an IS with an indication of thrombolysis and / or thrombectomy,&#xD;
      hospitalized in the neurovascular unit of Pierre Wertheimer Hospital (HCL) since January 2013&#xD;
      and until December 2030 will be contacted for this study&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 1, 2020</start_date>
  <completion_date type="Anticipated">March 2031</completion_date>
  <primary_completion_date type="Anticipated">March 2031</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Phenotype of the population</measure>
    <time_frame>3 months</time_frame>
    <description>Characterization the population of patients with stroke treated by thrombolysis and / or thrombectomy in the neurovascular unit of the Pierre Wertheimer Hospital, Hospices Civils de Lyon : age, sex, risk factors, becoming, etc.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">4500</enrollment>
  <condition>Ischemic Stroke</condition>
  <arm_group>
    <arm_group_label>Registry group</arm_group_label>
    <description>Patients over 18 years old, hospitalized in the neurovascular unit of the Pierre Wertheimer Neurological Hospital (Hospices Civils de Lyon), for an ischemic stroke treated by thrombolysis and / or mechanical thrombectomy and not opposed to this research</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Registry</intervention_name>
    <description>No specific intervention. Data of the usual care will be collected as the medical history, the demographic data, the biological analyses, imaging report, etc.</description>
    <arm_group_label>Registry group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients over 18 years old, hospitalized in the neurovascular unit of the Pierre Wertheimer&#xD;
        Neurological Hospital (Hospices Civils de Lyon), for an ischemic stroke treated by&#xD;
        thrombolysis and / or mechanical thrombectomy and not opposed to this research.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  - Patients over 18 years old,&#xD;
&#xD;
          -  Hospitalization in the neurovascular unit of the Pierre Wertheimer Neurological&#xD;
             Hospital (Hospices Civils de Lyon),&#xD;
&#xD;
          -  Ischemic stroke treated by thrombolysis and / or mechanical thrombectomy.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  - Opposition to this research.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Tae Hee CHO, MD</last_name>
    <phone>0033 4 72 35 78 07</phone>
    <email>tae-hee.cho@chu-lyon.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>MArielle BUISSON</last_name>
    <phone>0033 4 72 35 71 70</phone>
    <email>marielle.buisson01@chu-lyon.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>HÃ´pital Pierre Wertheimer, GHE, HCL</name>
      <address>
        <city>Lyon</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pr Tae-Hee CHO CHO, MD</last_name>
      <phone>0033 4 72 35 78 07</phone>
      <email>tae-hee.cho@chu-lyon.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>November 3, 2020</study_first_submitted>
  <study_first_submitted_qc>November 3, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 9, 2020</study_first_posted>
  <last_update_submitted>November 3, 2020</last_update_submitted>
  <last_update_submitted_qc>November 3, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Ischemic Stroke</keyword>
  <keyword>revascularisation therapy</keyword>
  <keyword>registry</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Ischemic Stroke</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

